Micro-Cap Biotech Gets Takeover Offer

Here are three takeover targets for the week Here are three takeover targets for the week                                                                                                      You are receiving this email because you are subscribed to Behind the Markets. If you no longer wish to receive these emails, please [unsubscribe]( here.  Dear Fellow Investor, Takeover deals can be a signal of positive market sentiment, indicating that the acquiring company is confident in its growth prospects and is willing to invest in expanding its market share. Such deals often lead to an increase in stock prices as they indicate potential value creation and synergies for the acquiring company. Takeover deals may provide an opportunity for investors to capitalize on market inefficiencies and earn profits through arbitrage strategies, such as buying the target company's stock at a discount to the offer price and profiting from the price convergence upon deal completion. Here are three takeover targets for the week - Pasithea Therapeutics Corp. – SYM: KTTA Recent Price: $0.59 Takeover Action: Lucy Scientific Discovery (LSDI), a licensed producer of compounds for medicinal products announced that it sent a proposal to Pasithea Therapeutics (KTTA), a biotechnology firm focused on innovative medical solutions, to acquire each share of its common stock. Description: Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for Central Nervous System disorders, RASopathies, and other diseases. It operates through two segments, Therapeutics and Clinics.  === [Reclusive Millionaire Shares Impressive 8-Year Win Streak]( See this revealing ‘tell all’ interview and discover the simple strategy that could turn every Friday into a payday. [Watch right now!]( === Avantax, Inc. – SYM: AVTA Recent Price: $25.89 [Get Takeover Action Here ]( Description: Avantax, Inc. provides wealth management solutions to consumers, small business owners, tax professionals, financial professionals, and certified public accounting firms in the United States. The company offers an integrated platform of technical, practice, compliance, operations, sales, and product support tools that enable to offer tax-advantaged planning, investing, and wealth management services. It also provides financial planning and advisory services, and retirement plan solutions. The company was formerly known as Blucora, Inc. and changed its name to Avantax, Inc. in January 2023. Avantax, Inc. was founded in 1983 and is headquartered in Dallas, Texas. === [The #1 Oil and Gas Income Play]( [oxford 63023]( It’s NOT a stock, bond or private company... But this little-known alternative investment could hand you BIG MONTHLY INCOME from the oil and gas surge in 2023. [CLICK HERE TO FIND OUT MORE]( === MoonLake Immunotherapeutics – SYM: MLTX Recent Price: $56.26 [Get Takeover Action Here ]( Description: MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or axial spondyloarthritis. MoonLake Immunotherapeutics was incorporated in 2021 and is headquartered in Zug, Switzerland. === [Closing: Learn The secret to seven-figures in 8 months [Outrageous but True]]( They've tweaked and optimized this system for 3 straight years and are looking for the next group of beta testers to join in and learn this simple trading strategy. [>> Apply here to become one of the 87 new beta testers <<]( "The Buck Stops Here" [youtube button]( [facebook button]( [instagram button]( Our mailing address is: Behind the Markets, LLC 4260 NW 1st Avenue, Suite 55 Boca Raton, FL 33431 Copyright © 2023 Behind the Markets, LLC, All rights reserved. You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our [Privacy Policy]( or our [Legal Notices.]( [Unsubscribe](